IL33 and inflammatory bowel disease: In patients with IBD, ILC2s were more frequently observed compared to their near absence in mucosal samples from non-IBD individuals [62], and IL-33 expression was correspondingly increased in the colonic tissue of both IBD patients and dextran sulfate sodium (DSS)-induced colitis [91].